In a statement issued on Thursday, the authority notified an increase of nine per cent in the retail price of life-saving drugs, while prices of other medicines will go up by 15 per cent.
The decision, according to the DRAP notification, has been approved by the federal government.
“Maximum retail prices of drugs may be increased under paragraph 12 (8) of the Drug Pricing Policy, 2018,” reads the notification. “Nine per cent over and above the maximum retail prices as determined under hardship category during the year 2018, and 15 per cent over and above the existing maximum retail prices determined under the Drug Pricing Policy, 2018 for drugs other than those specified in Clause (a).”
DRAP has directed for the revised prices to be printed on labels in the manner prescribed under the Drugs (Labeling and Packaging) Rules, 1986.
“The manufacturers and importers of drugs shall furnish calculations of revised maximum retail prices of drugs to the Division of Costing and Pricing of DRAP before implementing the increase.”The Drug Regulatory Authority of Pakistan (DRAP) fixed prices of packaging of 1,084 medicines and issued formal SROs with the approval of the government, it said in a statement on Wednesday.
Three SROs of the DRAP provide details of 898, 67 and 128 kinds of medicines that included brand names, compositions, names of manufacturing companies, sizes of packing and maximum retail prices of syrups, tablets, capsules and various injections.
The SROs directed companies that the prices fixed by DRAP should be printed on the packing.
The statement said that the new prices would not be applicable on the medicines which were registered earlier than the issuance of the notification while it would be mandatory for the manufacturers and importers of the medicines to present the RMP to the costing and pricing division of DRAP.
Tags:
Medicines